Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University Hospital

One Centre Follow-up Study on Safety and Efficacy

One centre follow-up study on safety and efficacy of treatment with rituximab among patients with RA during 4 year period. Basic data is collected for the national register of biologicals.

Data is collected on regular visits in the outpatient department. In collection national register forms have been used.

Inclusion Criteria:

• active RA without response to earlier treatment

Exclusion Criteria:

• contraindications to rituximab